Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma

Multiple Myeloma (MM) is an incurable neoplasm of mature B cells and the second most prevalent hematological malignancy worldwide. While combinations of proteasome inhibitors like bortezomib (Bz) and immunomodulators (IMiDs) like lenalinomide (Len) are generally effective in newly diagnosed patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Domenger, Antoine, Ricci, Daniela, Mayau, Véronique, Majlessi, Laleh, Marcireau, Christophe, Dadaglio, Gilles, Demangel, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911829/
https://www.ncbi.nlm.nih.gov/pubmed/36776330
http://dx.doi.org/10.3389/fonc.2023.1110916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911829/
https://www.ncbi.nlm.nih.gov/pubmed/36776330
http://dx.doi.org/10.3389/fonc.2023.1110916

Ejemplares similares